LD
Lim, Do Su
13 papers · 39 citations · 2024–2026
Publications
13
Citations
39
Years
3
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Dapagliflozin attenuates lipotoxic tenocyte injury via PPARα activation and irisin-driven antioxidant pathways
|
2026 | Article | 1 |
|
Ginsenoside Rg5 mitigates tenocyte death<i> via</i> SIRT6/autophagy-dependent signaling in an aging model
|
2026 | Article | 1 |
|
Urolithin A attenuates apoptosis and ferroptosis in hyperlipidemic tenocytes through PPARS/ALDH2-mediated antioxidative signaling
|
2025 | Article | 0 |
|
Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A
|
2025 | Article | 1 |
|
Resolvin D5: A lipid mediator with a therapeutic effect on hepatic steatosis through SIRT6/autophagy
|
2025 | Article | 0 |
|
Valdecoxib Ameliorates Apoptosis and Ferroptosis in Tenocytes via the SIRT6/NRF2-Mediated Suppression of Oxidative Stress
|
2025 | Article | 1 |
|
Myricetin promotes migration and prevents palmitate-induced apoptosis in cultured tenocytes through AMPK-dependent pathways
|
2025 | Article | 2 |
|
Donepezil alleviates hepatic steatosis by mitigating ER stress<i> via</i> the AMPK/ autophagy pathway
|
2025 | Article | 1 |
|
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis
|
2024 | Article | 12 |
|
Upadacitinib counteracts hepatic lipid deposition via the repression of JAK1/STAT3 signaling and AMPK/autophagy-mediated suppression of ER stress
|
2024 | Article | 8 |
|
Uvaol ameliorates lipid deposition in hyperlipidemic hepatocytes by suppressing protein-tyrosine phosphatase 1B/ER stress signaling
|
2024 | Article | 2 |
|
Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress
|
2024 | Article | 7 |
|
AMPK/autophagy-mediated alleviation of tendinopathy by IL-38: A novel strategy for the treatment of obesity-related tendinopathy
|
2024 | Article | 3 |